Analyses of public datasets have shown that elevated levels of soluble IL‐15/IL‐15Rα are associated with impaired NK cell functionality in late‐stage melanoma, while high expression correlates with improved survival in stages II and III.[334]. This evidence concerns the gene IL15 and melanoma.